Business
Wonder Drug for Male Baldness Sends Swiss Firm Cosmo’s Shares Soaring
Cosmo Pharmaceuticals shares jump nearly 40% after strong Phase III trial data for a new topical treatment for male pattern baldness.
1 stories
Cosmo Pharmaceuticals shares jump nearly 40% after strong Phase III trial data for a new topical treatment for male pattern baldness.
The stories that matter, in your inbox by 8 AM. Free, no spam.